<DOC>
	<DOC>NCT02175940</DOC>
	<brief_summary>This was a prospective, case-control study investigating aqueous levels of VEGF and PEDF in eyes with mCNV treated with IVB.</brief_summary>
	<brief_title>VEGF and PEDF in Patients With Myopic Choroidal Neovascularization</brief_title>
	<detailed_description />
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization, Pathologic</mesh_term>
	<mesh_term>Myopia</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<mesh_term>Pigment epithelium-derived factor</mesh_term>
	<criteria>pathologic myopia, defined as spherical equivalent &gt;6 diopters and axial length &gt;26 mm posterior pole myopic retinal changes (posterior staphyloma, chorioretinal atrophy, papillary crescent); fluorescein angiography, indocyanine green angiography and optical coherence tomography detection of the subfoveal or juxtafoveal choroidal neovascularization clear ocular media; previous treatment for choroidal neovascularization, including the previous intravitreal drug injection or PDT presence of other maculopathy as diabetic retinopathy or retinal vascular occlusion history of recent myocardial infarction or other thromboembolic events ongoing uncontrolled hypertension or glaucoma refractive media opacities previous eye surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>